Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MilliporeSigma™ Calbiochem™ Plasminogen Activator Inhibitor-1, Human, Recombinant

Catalog No. 52820550UG Shop All MilliporeSigma Products
Change view
Click to view available options
Quantity:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
52-820-550UG 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 52-820-550UG Supplier MilliporeSigma™ Supplier No. 52820550UG
Only null left
Add to Cart
Add to Cart

Primarily used for Protease Inhibitors applications.

PAI-1 is the primary inhibitor of both tissue plasminogen activator (tPA) and urokinase (uPA). PAI-1 can exist either in an active inhibitory conformation or in an inactive or latent conformation. This highly purified preparation has not been exposed to denaturing conditions and has been chromatographically purified of latent material. PAI-1 is a marker for acute myocardial infarction and several thrombolytic disorders. Protects platelets against the inhibitory effects of plasma. Reported to be an important prognostic factor in breast cancer patients. PAI-1 is highly stable when stored at or below pH 6.6.
TRUSTED_SUSTAINABILITY

Specifications

Formulation In 150 mM NaCl, 50 mM sodium phosphate buffer, 1 mM EDTA, pH 6.6.
Description 98% by SDS-PAGE
Target Proteins Tissue plasminogen activator (tPA) and urokinase (uPA)
Formula Weight 43000g/mol
Content And Storage Avoid Freeze-Thaw Cycles
Form Liquid
Quantity 50 μg
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.